Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma

Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma

Background: The immune landscape of hepatocellular carcinoma (HCC) is heterogeneous. This study aims to develop the immune type which could improve predictive value of HCC survival.Methods: A total of 208 HCC patients in the testing cohort, 112 patients in the validation cohort and 365 HCC patients...

Full description

Bibliographic Details
Main Authors: Wei Li, Lin Xu, Jun Han, Kefei Yuan, Hong Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Oncology
Subjects:
stromal immunotype
hepatocellular carcinoma
prognosis
LASSO COX
TCGA
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00664/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00664/full

Similar Items